Patent №
US 6,974,814
Granted
—
Owner
—
Lab
—
AI components
1
hardware
Assignment
None on record
Dataset
AIPD
2023_r1 edition
Application
10400265
The present invention relates to pharmacological methods for the prevention or amelioration of sleep-related breathing disorders via administration of agents or combinations of agents that possess glutamate-related and/or glycine-related pharmacological activity or that modulate the release of glutamate, glycine, or both from nerve terminals with the central nervous system.
AI hardwareA61K 31/662A61K 31/00A61K 31/13A61K 31/165A61K 31/198A61K 31/28A61K 31/35A61K 31/352+15 more
AI classification
AI hardware0.88
Speech0.38
Natural language0.01
Knowledge representation0.00
Machine learning0.00
Evolutionary computation0.00
Vision0.00
Planning0.00